TFEB and Parkinson disease: However, the precise molecular mechanisms underlying these neuroprotective effects remained elusive until 2023, when Wang and colleagues [56] first elucidated that morin improved PD pathology through a dual-action mechanism: it activated the AMPK-ULK1 signaling pathway and enhanced nuclear translocation of transcription factor EB (TFEB).